Shell Asset Management’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
AIM
BG
NAMA
GS
Shell Asset Management's CDNA Position: Q4 2023 in Review
Shell Asset Management sold out of CareDx (CDNA) in Q4 2023, closing a stake of 4,805 shares — an estimated $34K sold.
Shell Asset Management first reported a position in CDNA in Q1 2021 and held it in 11 quarters. The position peaked at $250K in Q2 2021. 147 funds tracked by Wall St. Rank hold CDNA as of Q4 2023.
- Shell Asset Management reported no remaining CareDx position as of Q4 2023 after selling out during the quarter.
- Shell Asset Management sold 4,805 CareDx shares in Q4 2023, an estimated $34K.
- Shell Asset Management first reported a position in CareDx in Q1 2021 and held it in 11 quarters.
- Shell Asset Management's CareDx position peaked at $250K in Q2 2021.
- 147 funds tracked by Wall St. Rank held CareDx as of Q4 2023.
Based on Shell Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.